Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.verified

SNPHF

Price:

$10.53

Market Cap:

$520.02B

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offe...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2010-06-09

Stock Exchange

PNK

Ticker

SNPHF

The ROE as of December 2024 (TTM) for Santen Pharmaceutical Co., Ltd. (SNPHF) is 8.82%

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.82%. This represents a change of 299.96% compared to the average of 2.20% of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (SNPHF) Historical ROE (quarterly & annually)

How has SNPHF ROE performed in the past?

The mean historical ROE of Santen Pharmaceutical Co., Ltd. over the last ten years is 8.60%. The current 8.82% ROE has changed 2.51% with respect to the historical average. Over the past ten years (40 quarters), SNPHF's ROE was at its highest in in the September 2015 quarter at 14.39%. The ROE was at its lowest in in the September 2022 quarter at -9.26%.

Quarterly (TTM)
Annual

Average

8.60%

Median

8.91%

Minimum

-5.08%

Maximum

20.53%

Santen Pharmaceutical Co., Ltd. (SNPHF) ROE by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 263.20%

Maximum Annual ROE = 20.53%

Minimum Annual Increase = -271.20%

Minimum Annual ROE = -5.08%

Quarterly (TTM)
Annual
YearROEChange
20248.70%-271.20%
2023-5.08%-163.05%
20228.06%263.20%
20212.22%-71.53%
20207.80%-28.98%
201910.98%-10.99%
201812.34%35.42%
20179.11%-55.62%
201620.53%80.89%
201511.35%20.19%

Santen Pharmaceutical Co., Ltd. (SNPHF) Average ROE

How has SNPHF ROE performed in the past?

The current ROE of Santen Pharmaceutical Co., Ltd. (SNPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.90%

5-year avg

4.34%

10-year avg

8.60%

Santen Pharmaceutical Co., Ltd. (SNPHF) ROE vs. Peers

How is SNPHF’s ROE compared to its peers?

Santen Pharmaceutical Co., Ltd.’s ROE is less than Ono Pharmaceutical Co., Ltd. (12.00%), less than GSK plc (18.08%), less than Grifols, S.A. (3.18%), less than Pfizer Inc. (4.72%),

CompanyROEMarket cap
12.00%$4.81B
18.08%$67.49B
3.18%$5.93B
4.72%$151.34B

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Santen Pharmaceutical Co., Ltd.'s ROE?

How is the ROE calculated for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the highest ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 3-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 5-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?

How does the current ROE for Santen Pharmaceutical Co., Ltd. (SNPHF) compare to its historical average?